Impact of Transcutaneous Spinal Stimulation on Blood Pressure and Orthostasis in Spinal Cord Injury

NCT07674511 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-06-29

No results posted yet for this study

Summary

The purpose of this study is to learn whether stimulation applied to the spinal cord through the skin (called transcutaneous spinal stimulation) can help control blood pressure in people with a spinal cord injury.

The main questions this study attempts to solve:

1. What are the immediate effects of spinal cord transcutaneous stimulation on BP?
2. Does stimulation produce lasting improvements in BP regulation and subsequently, daily function?

Conditions

  • Spinal Cord Injuries
  • Hypotension
  • Orthostatic Hypotension
  • Spinal Cord Diseases
  • Cardiovascular Diseases
  • Trauma, Nervous System
  • Central Nervous System Disease
  • Nervous System Diseases
  • Blood Pressure

Interventions

DEVICE

Tilt test with stimulation (real-time effects): Intervention 1

While lying supine, participants will be strapped to a Hi-Low tilt-table bed. The bed will gradually be tilted to a 70 degrees tilt, during which time continuous hemodynamic measures will be recorded. This position will be maintained for 30 minutes. During tilt, transcutaneous stimulation will be applied, using the configuration that was chosen based on the mapping sessions.

DEVICE

20 sessions of stimulation (Intervention 2)

Participants will undergo 20 separate 30-minute sessions of transcutaneous spinal cord stimulation while seated in their wheelchairs

Sponsors & Collaborators

  • Montclair State University

    collaborator OTHER
  • Kessler Foundation

    lead OTHER

Principal Investigators

  • Gail F Forrest, PhD · Kessler Foundation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2028-09-30
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07674511 on ClinicalTrials.gov